| Rheumatology | Lifetime | 233 | FR 10 | 99.06 |
| Nephrology | Lifetime | 130 | FR 4 | 99.01 |
| Rheumatology | 2021-2025 | 82 | FR 5 | 97.96 |
| Nephrology | 2021-2025 | 87 | FR 1 | 96.90 |
| Immunology | 2021-2025 | 882 | FR 31 | 67.14 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 25 | FR 2 | 99.01 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 164 | FR 4 | 99.11 |
| Case Reports on Hematomas | Lifetime | 16 | FR 2 | 98.85 |
| Inflammatory mediators and NSAID effects | Lifetime | 229 | FR 7 | 98.38 |
| Spondyloarthritis Studies and Treatments | Lifetime | 99 | FR 6 | 98.86 |
| Inflammasome and immune disorders | Lifetime | 325 | FR 21 | 96.86 |
| Urticaria and Related Conditions | Lifetime | 297 | FR 21 | 97.37 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 567 | FR 35 | 97.75 |
| Dermatological and Skeletal Disorders | Lifetime | 223 | FR 17 | 95.56 |
| Eosinophilic Disorders and Syndromes | Lifetime | 791 | FR 65 | 94.78 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 680 | FR 31 | 95.15 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 702 | FR 20 | 92.61 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 944 | FR 78 | 89.09 |
| Medicinal plant effects and applications | Lifetime | 414 | FR 7 | 84.56 |
| Alkaline Phosphatase Research Studies | Lifetime | 738 | FR 34 | 79.86 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 757 | FR 32 | 64.25 |
| Heterotopic Ossification and Related Conditions | Lifetime | 968 | FR 47 | 60.93 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 398 | FR 44 | 40.71 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 18 | FR 1 | 97.16 |
| Case Reports on Hematomas | 2021-2025 | 10 | FR 1 | 94.06 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 110 | FR 5 | 96.61 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 259 | FR 12 | 96.04 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 267 | FR 3 | 94.30 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 294 | FR 11 | 93.13 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 344 | FR 16 | 92.30 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 388 | FR 6 | 73.36 |
| Alkaline Phosphatase Research Studies | 2021-2025 | 112 | FR 10 | 58.38 |
| Dermatological and Skeletal Disorders | 2021-2025 | 683 | FR 46 | 47.22 |
| Heterotopic Ossification and Related Conditions | 2021-2025 | 481 | FR 24 | 22.33 |
| Whipple's Disease and Interleukins | 2021-2025 | 142 | FR 27 | 15.73 |